Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythrocyte carriers.

G M Ihler, H C Tsang

    Critical Reviews in Therapeutic Drug Carrier Systems
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Erythrocytes, or red blood cells, show potential as carriers for delivering drugs, enzymes, and DNA. These loaded cells can target specific organs or modify drug pharmacokinetics, offering new therapeutic delivery strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Artificial intelligence analysis of chest X-ray and computed tomographic images for COVID-19 patient management: abridged secondary publication.

    Hong Kong medical journal = Xianggang yi xue za zhi·2025
    Same author

    Deformin, a substance found in Bartonella bacilliformis culture supernatants, is a small, hydrophobic molecule with an affinity for albumin.

    Blood cells, molecules & diseases·2002
    Same author

    Why did the 5th Earl of Derby die?

    Lancet (London, England)·2001
    Same author

    Formation of stress fibres in human endothelial cells infected with Bartonella bacilliformis is associated with altered morphology, impaired migration and defects in cell morphogenesis.

    Cellular microbiology·2001
    Same author

    Infection of human endothelial cells with Bartonella bacilliformis is dependent on Rho and results in activation of Rho.

    Infection and immunity·2000
    Same author

    Comparison of the abilities of proteins from Bartonella bacilliformis and Bartonella henselae to deform red cell membranes and to bind to red cell ghost proteins.

    FEMS microbiology letters·1998
    Same journal

    Unveiling the Potential of Drug Delivery Systems for Tyrosine Kinase Inhibitors in the Treatment of Neovascular Eye Diseases.

    Critical reviews in therapeutic drug carrier systems·2026
    Same journal

    Investigation of Bioinspired Nanocurcumin Composites for Antibacterial Applications.

    Critical reviews in therapeutic drug carrier systems·2026
    Same journal

    Advances in the Preparation of Lipid-Based Nanotechnologies: Expanding the Horizons of Therapeutic Applications.

    Critical reviews in therapeutic drug carrier systems·2026
    Same journal

    Nano Lipid Carriers (NLCs): Potential and Promises in Drug Delivery.

    Critical reviews in therapeutic drug carrier systems·2026
    Same journal

    CpG ODNs: Precision Immunotherapy and Recent Trends in Nano-Enabled Nucleotide Delivery.

    Critical reviews in therapeutic drug carrier systems·2026
    Same journal

    Plant-Based Exosomes: Insights and Therapeutic Applications.

    Critical reviews in therapeutic drug carrier systems·2026
    See all related articles

    Area of Science:

    • Biotechnology and Biomedical Engineering
    • Drug Delivery Systems
    • Cellular Therapeutics

    Background:

    • Erythrocytes (red blood cells) possess unique properties making them candidates for advanced biological applications.
    • Current drug delivery methods face challenges in targeting and sustained release.
    • Cellular carriers offer potential for improved therapeutic efficacy and reduced side effects.

    Purpose of the Study:

    • To review the properties of erythrocytes as carriers for drugs, enzymes, and DNA.
    • To explore the potential applications of erythrocyte-based delivery systems.
    • To discuss the mechanisms of cellular fusion and content transfer.

    Main Methods:

    • Review of existing literature on erythrocyte properties and applications.

    Related Experiment Videos

  • Analysis of erythrocyte interactions with recipient cells (erythrophagocytosis).
  • Evaluation of in vitro erythrocyte fusion and content transfer capabilities.

    • Main Results:

    • Erythrocytes can be loaded with drugs, enzymes, and nucleic acids (DNA/RNA).
    • Loaded erythrocytes can target cells involved in erythrophagocytosis, primarily in the liver and spleen.
    • Erythrocytes can modify drug pharmacokinetics and plasma substance levels when used as carriers.
    • In vitro studies demonstrate erythrocyte fusion with recipient cells, enabling functional content delivery.

    Conclusions:

    • Erythrocytes represent a promising platform for targeted drug, enzyme, and nucleic acid delivery.
    • Their ability to survive in circulation and interact with specific cells enhances therapeutic potential.
    • Erythrocyte-mediated delivery offers a novel approach for modifying pharmacokinetics and cellular function.